Why is Tatva Chintan Pharma Chem Ltd ?
- PAT(Q) At Rs 9.92 cr has Grown at 454.2% (vs previous 4Q average)
- NET SALES(Q) Highest at Rs 123.52 cr
- PBDIT(Q) Highest at Rs 22.22 cr.
- The stock has generated a return of 55.50% in the last 1 year, much higher than market (BSE500) returns of 2.12%
How much should you buy?
- Overall Portfolio exposure to Tatva Chintan should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Tatva Chintan for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 12.65 cr has Grown at 568.4% (vs previous 4Q average
Highest at Rs 22.22 cr.
Highest at 17.99%
Highest at Rs 9.92 cr.
Highest at 40.95%
At Rs 123.52 cr has Grown at 25.4% (vs previous 4Q average
Highest at Rs 4.24
Lowest at Rs 24.67 Cr
Lowest at 4.28 times
Here's what is working for Tatva Chintan
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
EPS (Rs)
DPR (%)
Here's what is not working for Tatva Chintan
Debtors Turnover Ratio
Operating Cash Flows (Rs Cr)






